| |
| |
|
| Insider
Information: |
Klausner Richard |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,990,681 |
|
|
Indirect Shares
|
930,880 |
|
|
| Direct
Value |
$10,403,702 |
|
|
|
Indirect Value
|
$2,485,450 |
|
|
| Total
Shares |
3,921,561 |
|
|
| Total
Value |
$12,889,151 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -36.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Illumina Inc |
ILMN |
Sr VP, Chief Medical O... |
2016-01-29 |
22,847 |
|
0 |
Premium* |
|
|
Juno Therapeutics, Inc. |
JUNO |
Director |
2018-03-05 |
0 |
|
0 |
Premium* |
|
|
Lyell Immunopharma, Inc. |
LYEL |
Director |
2023-08-15 |
2,967,834 |
2023-08-15 |
930,880 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ILMN |
Illumina Inc |
Sr VP, Chief Medical OfficerOf |
• – – |
2013-10-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
22,570 |
|
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2014-12-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
982,499 |
|
- |
|
| ILMN |
Illumina Inc |
Sr VP, Chief Medical Officer |
• – – |
2014-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,344 |
24,914 |
0 |
- |
|
| ILMN |
Illumina Inc |
Sr VP, Chief Medical Officer |
• – – |
2014-12-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,975 |
26,380 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
300 |
882,799 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
300 |
847,099 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2016-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
401 |
847,500 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
591 |
848,091 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
514 |
848,605 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
380 |
824,985 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
266 |
777,251 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2018-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
248 |
741,499 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2018-02-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
23,250 |
705,525 |
0 |
- |
|
| LYEL |
Lyell Immunopharma, Inc. |
Executive Chairman |
• • – |
2021-06-21 |
4 |
A |
$0.00 |
$0 |
I/I |
3,765,842 |
3,765,842 |
0 |
- |
|
| ILMN |
Illumina Inc |
Sr VP, Chief Medical Officer |
• • – |
2015-11-05 |
4 |
D |
$154.75 |
$28,784 |
D/D |
(186) |
23,830 |
0 |
- |
|
| ILMN |
Illumina Inc |
Sr VP, Chief Medical Officer |
• • – |
2016-01-29 |
4 |
D |
$157.95 |
$39,961 |
D/D |
(253) |
22,847 |
0 |
- |
|
| ILMN |
Illumina Inc |
Sr VP, Chief Medical Officer |
• – – |
2015-01-29 |
4 |
D |
$200.00 |
$49,200 |
D/D |
(246) |
26,134 |
0 |
- |
|
| LYEL |
Lyell Immunopharma, Inc. |
Director |
– • – |
2022-09-23 |
4 |
S |
$6.40 |
$71,041 |
I/I |
(11,100) |
988,900 |
0 |
% |
|
| ILMN |
Illumina Inc |
Sr VP, Chief Medical Officer |
• • – |
2015-09-28 |
4 |
AS |
$173.20 |
$73,264 |
D/D |
(423) |
24,016 |
0 |
- |
|
| ILMN |
Illumina Inc |
Sr VP, Chief Medical Officer |
• – – |
2014-09-23 |
4 |
D |
$167.27 |
$85,140 |
D/D |
(509) |
24,405 |
0 |
- |
|
| ILMN |
Illumina Inc |
Sr VP, Chief Medical Officer |
• • – |
2015-09-23 |
4 |
D |
$189.93 |
$96,674 |
D/D |
(509) |
24,439 |
0 |
- |
|
| ILMN |
Illumina Inc |
Sr VP, Chief Medical Officer |
• • – |
2015-11-13 |
4 |
AS |
$163.52 |
$119,370 |
D/D |
(730) |
23,100 |
0 |
- |
|
| LYEL |
Lyell Immunopharma, Inc. |
Director |
– • – |
2023-08-15 |
4 |
S |
$2.28 |
$132,286 |
I/I |
(58,020) |
930,880 |
0 |
% |
|
| ILMN |
Illumina Inc |
Sr VP, Chief Medical Officer |
• – – |
2015-03-10 |
4 |
AS |
$191.75 |
$227,416 |
D/D |
(1,186) |
24,948 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
Director |
– • – |
2017-08-07 |
4 |
AS |
$30.34 |
$364,091 |
D/D |
(12,000) |
788,985 |
0 |
- |
|
42 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
